Cargando…
Factor VIII haplotypes frequencies in Tunisian hemophiliacs A
BACKGROUND: The development of inhibitors against factor 8 (F8) is the most serious complication of replacement therapy with F8 in children with severe hemophilia. It was suggested that mismatched F8 replacement therapy may be a risk factor for the development of anti-factor F8 alloantibodies. Recen...
Autores principales: | Elmahmoudi, Hejer, Belhedi, Nejla, Jlizi, Asma, Zahra, Kaouther, Meddeb, Balkis, Elgaaied, Amel Ben Ammar, Gouider, Emna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148954/ https://www.ncbi.nlm.nih.gov/pubmed/21682900 http://dx.doi.org/10.1186/1746-1596-6-54 |
Ejemplares similares
-
First report of molecular diagnosis of Tunisian hemophiliacs A: Identification of 8 novel causative mutations
por: Elmahmoudi, Hejer, et al.
Publicado: (2012) -
The Glanzmann’s Thrombasthenia in Tunisia: A Cohort Study
por: Elmahmoudi, Hejer, et al.
Publicado: (2017) -
Identification of genetic defects underlying FVII deficiency in 10 patients belonging to eight unrelated families of the North provinces from Tunisia
por: Elmahmoudi, Hejer, et al.
Publicado: (2012) -
A new locus on chromosome 22q13.31 linked to recessive genetic epilepsy with febrile seizures plus (GEFS+) in a Tunisian consanguineous family
por: Belhedi, Nejla, et al.
Publicado: (2013) -
Factor XI deficiency: About 20 cases and literature review
por: Dhaha, Yosra, et al.
Publicado: (2022)